McNeil Asks High Court To Review Drug Failure To Warn

Law360, New York (December 3, 2010, 7:57 PM EST) -- McNeil-PPC Inc. has asked the U.S. Supreme Court to consider the question of whether federal law, which imposes a strict set of labeling requirements on makers of over-the-counter drugs including mandatory U.S. Food and Drug Administration product warnings, preempts state law product liability actions based on theories of failure to warn.

The pharmaceutical company filed a petition Tuesday in the high court, prompted by a Florida state court ruling that state law failure to warn claims were not in fact preempted by federal law.

OTC drug...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.